Long-term overexpression of heme oxygenase 1 promotes tau aggregation in mouse brain by inducing tau phosphorylation

Journal of Alzheimer's Disease

Volumn 26, Issue 2, 2011, Pages 299-313

  Hui, Yang ^a   Wang, Dayong ^a   Li, Wenjing ^a,b   Zhang, Lina ^a,c   Jin, Jianfeng ^a   Ma, Ning ^a   Zhou, Lingyun ^a   Nakajima, Osamu ^d   Zhao, Weiming ^a   Gao, Xu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b ADICON Clinical Laboratories   (China)

^c DAQING OILFIELD CO LTD   (China)

^d YAMAGATA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; heme oxygenase 1; iron; tau; transgenic mice

Indexed keywords

HEME OXYGENASE 1; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN VIVO STUDY; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE;

EID: 80052800581     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-102061     Document Type: Article

References (57)

1. Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362, 329-344.
2. Goedert M, Klug A, Crowther R (2006) Tau protein, the paired helical filament and Alzheimer's disease. J Alzheimers Dis 9, 195-207. (Pubitemid 44253313)
3. Maccioni RB, Faŕias G, Morales I, Navarrete L (2010) The revitalized tau hypothesis on Alzheimer's disease. Arch Med Res 41, 226-231.
4. Stoothoff WH, Johnson GV (2005) Tau phosphorylation: physiological and pathological consequences. Biochim Bio-phys Acta 1739, 280-297. (Pubitemid 40018545)
5. Ryter SW, Tyrrell RM (2000) The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro-and antioxidant properties. Free Radic Biol Med 28, 289-309. (Pubitemid 30084022)
6. Vincent SR, Das S, Maines MD (1994) Brain heme oxygenase isoenzymesand nitric oxide synthase are co-localizedinselect neurons. Neuroscience 63, 223-231. (Pubitemid 24333963)
7. Ham D, Schipper HM (2000) Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides. Cell Mol Biol (Noisy-le-grand) 46, 587-596.
8. Butterfield DA, Griffin S, Munch G, Pasinetti GM (2002) Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. J Alzheimers Dis4, 193-201. (Pubitemid 35006051)
9. Schipper HM, Cissé S, Stopa EG (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 37, 758-768.
10. Schipper HM, Bennett DA, Liberman A, Bienias JL, Schneider JA, Kelly J, Arvanitakis Z (2006) Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 27, 252-261. (Pubitemid 43038549)
11. Smith MA, Kutty RK, Richey PL, Yan SD, Stern D, Chader GJ, Wiggert B, Petersen RB, Perry G (1994) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 145, 42-47. (Pubitemid 24217481)
12. Schipper HM (2011) Heme oxygenase-1 in Alzheimer disease: a tribute to Moussa Youdim. J Neural Transm 118, 381-387.
13. Hogan B, Constanlini F, Lancy E (1986) Manipulating the Mouse Embryo. Cold Spring Harbor. NY, 332 pp.
14. Kawahara K, Hashimoto M, Bar-On P, Ho GJ, Crews L, Mizuno H, Rockenstein E, Imam SZ, Masliah E (2008) Alpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson disease. J Biol Chem 283, 6979-6987.
15. Foy AL, Williams HL, Cortell S, Conrad ME (1967) A modified procedure for the determinationofnonheme ironintissue. Anal Biochem 18, 559-563.
16. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 103, 26-35. (Pubitemid 36075309)
17. Egana JT, Zambrano C, Nunez MT, Gonzalez-Billault C, Maccioni RB (2003) Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures. Biometals 16, 215-223. (Pubitemid 36140231)
18. Takeda A, Perry G, Abraham NG, Dwyer BE, Kutty RK, Laitinen JT, Petersen RB, Smith MA (2000) Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau. J Biol Chem 275, 5395-5399. (Pubitemid 30115170)
19. Song W, Patel A, Qureshi HY, Han D, Schipper HM, Paudel HK (2009) The Parkinson disease-associated A30 P mutation stabilizes alpha-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells. J Neurochem 110, 719-733.
20. Yamamoto A, Shin RW, Hasegawa K, Naiki H, Sato H, Yoshimasu F, Kitamoto T (2002) Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease. J Neurochem 82, 1137-1147. (Pubitemid 34966626)
21. Zhu X, Rottkamp CA, Boux H, Takeda A, Perry G, Smith MA (2000) Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J Neuropath Exp Neurol 59, 880-888.
22. Zhu X, Raina AK, Lee H, Casadesus G, Smith MA, Perry G (2004) Oxidative stress signaling in Alzheimer's disease. Brain Res 1000, 32-39. (Pubitemid 38446487)
23. Kondziella D, Zetterberg H (2008) Hyperphosphorylation of tau protein in superficial CNS siderosis. J Neurol Sci 273, 130-132.
24. Schipper HM (1999) Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases. Neurotox Res 1, 57-70.
25. Dwyer BE, Nishimura RN, Lu SY (1995) Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res Mol Brain Res 30, 37-47.
26. Panizzon KL, Dwyer BE, Nishimura RN, Wallis RA (1996) Neuroprotection against CA1 injury with metalloporphyrins. Neuroreport 7, 662-666. (Pubitemid 26106190)
27. Fukuda K, Richmon JD, Sato M, Sharp FR, Panter SS, Noble LJ (1996) Induction of heme oxygenase-1 (HO-1) inglia after traumatic brain injury. Brain Res 736, 68-75. (Pubitemid 26358000)
28. Beschorner R, Adjodah D, Schwab JM, Mittelbronn M, Pedal I, Mattern R, Schluesener HJ, Meyermann R (2000) Long-term expression of heme oxygenase-1 (HO-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans. Acta Neuropathol 100, 377-384. (Pubitemid 30497006)
29. Ahmad AS, Ahmad M, deBrum-Fernandes AJ, Doré S (2005) Prostaglandin EP4 receptor agonist protects against acute neu-rotoxicity. Brain Res 1066, 71-77. (Pubitemid 41790730)
30. Stocker R, Yamamoto Y, Mc Donagh AF, Glazer AN, Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043-1046. (Pubitemid 17049750)
31. Nakagami T, Toyomura K, Kinoshita T, Morisawa S (1993) A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1158, 189-193. (Pubitemid 23291461)
32. Llesuy SF, Tomaro ML (1994) Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim Biophys Acta 1223, 9-14. (Pubitemid 24262847)
33. Doré S, Sampei K, Goto S, Alkayed NJ, Guastella D, Black-shaw S, Gallagher M, Traystman RJ, Hurn PD, Koehler RC, Snyder SH (1999) Heme oxygenase-2 is neuroprotective in cerebral ischemia. Mol Med 5, 656-663. (Pubitemid 32937025)
34. Barañano DE, Snyder SH (2001) Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc Natl Acad Sci USA 98, 10996-11002. (Pubitemid 32928673)
35. Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella LF, Ikehara S, Wolin MS, Abraham NG (2005) Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Cire Physiol 289, H701-H707. (Pubitemid 41129386)
36. Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, Agarwal A (2004) Heme oxygenase-1 modulates early inflammatory responses evidence from the heme oxygenase-1 deficient mouse. Am J Pathol 165, 1045-1053. (Pubitemid 39129309)
37. Wang X, Wang Y, Kim HP, Nakahira K, Ryter SW, Choi AM (2007) Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J Biol Chem 282, 1718-1726. (Pubitemid 47076716)
38. Brouard S, Berbera P, Tobiasche E, Seldon MP, Bach FH, Soares MP (2002) Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-/cB to protect endothlial cells from tumor necrisis factor-α-mediated apoptosis. J Biol Chem 277, 17950-17961. (Pubitemid 34967606)
39. Cuadrado A, Rojo AI (2008) Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections. Curr Pharm Design 14, 429-442. (Pubitemid 351516848)
40. Song L, Song W, Schipper HM (2007) Astroglia overexpress-ing heme oxygenase-1 predispose co-cultured PC12 cells to oxidative injury. J Neurosci Res 85, 2186-2195. (Pubitemid 47172150)
41. Zukor H, Song W, Liberman A, Mui J, Vali H, Fillebeen C, Pantopoulos K, Wu TD, Guerquin-Kern JL, Schipper HM (2009) HO-1-mediated macroautophagy: a mechanism for unregulated iron deposition in aging and degenerating neural tissues. J Neurochem 109, 776-791.
42. Baranano DE, Rao M, Ferris CD, Snyder SH (2002). Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99, 16093-16098. (Pubitemid 35462754)
43. Liu Y, Li P, Lu J, Xiong W, Oger J, Tetzlaff W, Cynader M (2008) Bilirubin possesses powerful immunomodu-latory activity and suppresses experimental autoimmune encephalomyelitis. J Immunol 181, 1887-1897.
44. Cashore WJ (1990) The neurotoxicity of bilirubin. Clin Perinatol 17, 437-448.
45. Desmard M, Boczkowski J, Poderoso J, Motterlini R (2007) Mitochondrial and cellular heme-dependent proteins as targets for the bioactive function of the heme oxygenase/carbon monoxide system. Antioxid Redox Signal 9, 2139-2155. (Pubitemid 350059023)
46. Egaña JT, Zambrano C, Nunez MT, Gonzalez-Billault C, Maccioni RB (2003) Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures. Biometals 16, 215-223. (Pubitemid 36140231)
47. Ke Y, Ming Qian Z (2003) Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2, 246-253. (Pubitemid 37443312)
48. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5, 863-873. (Pubitemid 39482155)
49. Hartman D (1995) Free radical theory of aging: Alzheimer's disease pathogenesis. AGE 18, 97-119.
50. Halliwell B, Gutteridge JMC (1989) Free radicals in biology and medicine. Oxford, United Kingdom: Oxford University Press.
51. Packer L, Prilipko L, Christen Y, (eds). (1992) Free radicals in the brain. Springer-Verlag, Heidelberg, Germany.
52. Hirose W, Ikematsu K, Tsuda R (2003) Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. Leg Med (Tokyo) 5 Suppl1, S360-S366. (Pubitemid 36537911)
53. Dennery PA (2000) Regulation and role of heme oxygenase in oxidative injury. Curr Top Cell Regul 36, 181-199.
54. Schipper HM (2000) Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol 35, 821-830.
55. Loboda A, Jazwa A, Grochot-Przeczek A, Rutkowski AJ, Cisowski J, Agarwal A, Jozkowicz A, Dulak J (2008) Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 10, 1767-1812.
56. Schipper HM (2007) The role of biologic markers in the diagnosis of Alzheimer's disease. Alzheimers Dement 3, 325-332. (Pubitemid 47553567)
57. Mueller C, Zhou W, Vanmeter A, Heiby M, Magaki S, Ross MM, Espina V, Schrag M, Dickson C, Liotta LA, Kirsch WM (2010) The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease. J Alzheimers Dis 19, 1081-1091.